Gilead Sciences Foster City Pharmaceutical Manufacturing Hub

Deal value: $180,000,000

Gilead Sciences began construction of a 180,000 SF, five-story pharmaceutical development and manufacturing hub at its Foster City HQ, supporting next-gen therapies and consolidating R&D and manufacturing.

The core motivation is to strengthen Gilead’s leadership in next-generation therapies by consolidating R&D and manufacturing in a digitally advanced, AI-enabled hub. This investment is driven by the need to accelerate biologics innovation, enhance supply chain resilience, and support U.S. biopharma competitiveness. The timing aligns with both Gilead’s multi-year growth strategy and broader policy momentum favoring domestic manufacturing and technological advancement.